Back to List

Regulations for Registration of Medicinal Products - Article 74

Regulations for Registration of Medicinal Products|第 74 條|Food and Drug Administration|Regulation|In Force

第 三 章/第 一 節|衛生福利部|v1.0

Effective Date: 2024-01-01|Last Amended: 2023-04-27

Content

The testing specifications for Chinese medicine, as provided in this Chapter, are based on the Taiwan Herbal Pharmacopeia, Chinese Pharmacopoeia, or other foreign pharmacopoeias or announcements acknowledged by the central health authority. References can only be taken from the last two editions; nevertheless, the testing specifications for Chinese medicine preparation shall be based on the latest edition of the Taiwan Herbal Pharmacopeia or Chinese Pharmacopoeia. In the event that the testing specifications set forth in the preceding paragraph are not listed in the Taiwan Herbal Pharmacopoeia or Chinese Pharmacopoeia or are not covered by any other foreign pharmacopoeias or announcements acknowledged by the central health authority, manufacturers and importers shall establish the testing specifications at their own discretion based on their actual needs.

Related Regulations - Regulations for Registration of Medicinal Products

  • Regulations for Registration of Medicinal Products - Article 70(第 70 條)
  • Regulations for Registration of Medicinal Products - Article 81(第 81 條)
  • Regulations for Registration of Medicinal Products - Article 75(第 75 條)
  • Regulations for Registration of Medicinal Products - Article 76(第 76 條)
  • Regulations for Registration of Medicinal Products - Article 76-1(第 76-1 條)
  • Regulations for Registration of Medicinal Products - Article 76-2(第 76-2 條)
  • Regulations for Registration of Medicinal Products - Article 76-3(第 76-3 條)